Wilson Martin plan to sell securities of ROCKET PHARMACEUTICALS, INC. under Form 144

Wilson Martin filed Form 144 to notify SEC of plan to sell 3361 units of ROCKET PHARMACEUTICALS, INC. securities around 2026-05-13, with aggregate market value of $12,118.42. The total outstanding units is 109193549.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 02/13/2026, sold 12253 units for $40583.16; On 02/18/2026, sold 1376 units for $4593.78;